Mattias Collin

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Candida Albicans

Regulatory T Cells

Top Venues

The Journal of experimental medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Lotta J Happonen, Mattias Collin
Immunomodulating Enzymes from Streptococcus pyogenes -In Pathogenesis, as Biotechnological Tools, and as Biological Drugs. Microorganisms 12 (1) (2024)
Lotta J Happonen, Mattias Collin
Immunomodulating Enzymes from Streptococcus pyogenes -In Pathogenesis, as Biotechnological Tools, and as Biological Drugs. Microorganisms 12 (1) (2024)
Lotta J Happonen, Mattias Collin
Immunomodulating Enzymes from Streptococcus pyogenes -In Pathogenesis, as Biotechnological Tools, and as Biological Drugs. Microorganisms 12 (1) (2024)
Alejandro Gomez Toledo, Eleni Bratanis, Erika Velásquez, Sounak Chowdhury, Berit Olofsson, James T Sorrentino, Christofer A Q Karlsson, Nathan E Lewis, Jeffrey D Esko, Mattias Collin, Oonagh Shannon, Johan Malmstöm
Pathogen-driven degradation of endogenous and therapeutic antibodies during streptococcal infections. Nature communications 14 (1) (2023)
Andreas Naegeli, Eleni Bratanis, Christofer A Q Karlsson, Oonagh Shannon, Raja Kalluru, Adam Linder, Johan Malmstöm, Mattias Collin
Streptococcus pyogenes evades adaptive immunity through specific IgG glycan hydrolysis. The Journal of experimental medicine 216 (7) (2019)
Alex Bersellini Farinotti, Gustaf Wigerblad, Diana Sofia Marques Nascimento, Duygu B Bas, Carlos Morado Urbina, Kutty Selva Nandakumar, Katalin Sandor, Bingze Xu, Sally Abdelmoaty, Matthew A Hunt, Kristina Ängeby Möller, Azar Baharpoor, Jon Sinclair, Kent Jardemark, Johanna T Lanner, Ia Khmaladze, Lars E Borm, Lu Zhang, Fredrik Wermeling, Mark S Cragg, Johan Lengqvist, Anne-Julie Chabot-Doré, Luda Diatchenko, Inna Belfer, Mattias Collin, Kim Kultima, Birgitta Heyman, Juan Miguel Jimenez-Andrade, Simone Codeluppi, Rickard Holmdahl, Camilla I Svensson
Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons. The Journal of experimental medicine 216 (8) (2019)